2/16/2018 Contest update
My Contest update begins below, but I feel that I can’t ignore the latest horrific mass shooting in the U.S., this time at a Florida high school. As biotech investors and participants in the Charity Contest, I assume you’re not just in it for the money but also to help save lives. So, I’m sure all of you, as I was, were greatly distressed when you learned about yet another mass killing in our nation.
Along with being distressed, I’m also angry, my anger being especially directed at the NRA and its bought-off, craven politicians. This LA Times article describes how the NRA exerts its malevolent influence through campaign spending to the extent that Congress refuses to even prohibit those on the terrorist watch list from buying guns or even fund research on gun violence:
latimes.com
And here’s an article providing evidence that the proliferation of guns in the U.S. is by far the major reason our country leads the world by huge numbers in mass shootings and other gun violence:
nytimes.com
The update:
At Friday’s close, the Contest median was up 12.65% YTD (vs. up 7.18% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 3.38% YTD (vs. down -.92% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 8.96% YTD (vs. up 2.54% YTD a week ago), with the Nasdaq Composite Index (IXIC) up 4.87% YTD (vs. down -0.42% YTD a week ago).
RKRW’s portfolio, up 36.86% YTD, climbed back into the lead, with JULIUS’ portfolio, up 29.12% YTD, riding the SRNE rocket to second place and SPTAD’s portfolio, up 27.47% YTD, dropping to third place.
At Friday's close, 56 of the 62 Contest portfolios were in the green, with 52 beating the NBI and 36 beating the SPSIBI.
The 230 Contest stock picks have an average YTD gain of 9.06% and a median YTD gain of 4.20%.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: AVIR merged into Vaxart, with symbol change to VXRT. Along with merger, the company did 1-11 reverse split.
(All corrections, especially adjustments for splits & mergers, greatly appreciated.)
Enjoy a safe President’s Day weekend biotechies!
Peace & good health,
Bulba
2/16/18
Rank Name Profit/Loss
1 RKRW 36,856
2 JULIUS 29,122
3 SPTAD 27,466
4 KEOKA 27,193
5 MARKETH 25,515
6 TUCK 25,348
7 STEVEL 25,176
8 THID 23,010
9 BIOCQR 22,422
10 FILO 22,305
Week's Top 5 Gainers
Symbol 2/9/18 2/16/18 Wk.%chg.
ATE.V 0.21 0.29 35.71%
WVE 41.25 54.70 32.61%
ASMB 42.85 56.82 32.60%
CATB 1.23 1.60 30.08%
SRNE 6.80 8.75 28.68%
Week's Worst 5 Losers
Symbol 2/9/18 2/16/18 Wk.%chg.
TTPH 5.15 2.12 -58.83%
APRI 2.31 1.04 -54.98%
GLMD 9.330 5.920 -36.55%
VXRT 8.36 6.30 -24.62%
KDMN 4.79 3.63 -24.22%
|
